Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial.

Balighi K, Daneshpazhooh M, Khezri S, Mahdavi-nia M, Hajiseyed-javadi M, Chams-Davatchi C.

Int J Dermatol. 2013 Jul;52(7):862-7. doi: 10.1111/j.1365-4632.2012.5847.x. Erratum in: Int J Dermatol. 2013 Oct;52(10):1292. Kamran, Balighi [corrected to Balighi, Kamran]; Maryam, Daneshpazhooh [corrected to Daneshpazhooh, Maryam]; Somayeh, Khezri [corrected to Khezri, Somayeh]; Mostafa, Mahdavi-nia [corrected to Mahdavi-nia, Mostafa]; Mahsa, Hajiseyed-javadi [corrected to Hajiseyed-javadi, Mahsa]; Cheyda, Chams-Davatchi [corrected to Chams-Davatchi, Cheyda].

PMID:
23789604
2.

Lung abscess as a complication of steroid treatment in pemphigus vulgaris.

Manfredini R, Delli Gatti C, la Cecilia O, Boari B, Gallerani M, Altieri E.

Arch Intern Med. 2001 Sep 10;161(16):2044-5. No abstract available.

PMID:
11525709
3.

Occult lung abscess complicating high-dosage corticosteroid therapy.

Stein KM, Raque CJ, Harrell DD, Samitz MH.

Postgrad Med. 1972 Apr;51(4):97-101. No abstract available.

PMID:
5027892
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk